Clinical Trial Update: Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating lapatinib in patients with hormone-refractory prostate cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-06-28